1. Home
  2. BEAT vs LOAN Comparison

BEAT vs LOAN Comparison

Compare BEAT & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • LOAN
  • Stock Information
  • Founded
  • BEAT 2015
  • LOAN 1989
  • Country
  • BEAT United States
  • LOAN United States
  • Employees
  • BEAT N/A
  • LOAN N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • LOAN Real Estate Investment Trusts
  • Sector
  • BEAT Technology
  • LOAN Real Estate
  • Exchange
  • BEAT Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • BEAT 59.8M
  • LOAN 64.4M
  • IPO Year
  • BEAT 2021
  • LOAN 1999
  • Fundamental
  • Price
  • BEAT $2.22
  • LOAN $5.52
  • Analyst Decision
  • BEAT Buy
  • LOAN
  • Analyst Count
  • BEAT 1
  • LOAN 0
  • Target Price
  • BEAT $8.00
  • LOAN N/A
  • AVG Volume (30 Days)
  • BEAT 78.6K
  • LOAN 27.4K
  • Earning Date
  • BEAT 11-12-2024
  • LOAN 10-22-2024
  • Dividend Yield
  • BEAT N/A
  • LOAN 8.33%
  • EPS Growth
  • BEAT N/A
  • LOAN 12.78
  • EPS
  • BEAT N/A
  • LOAN 0.50
  • Revenue
  • BEAT N/A
  • LOAN $7,437,330.00
  • Revenue This Year
  • BEAT N/A
  • LOAN N/A
  • Revenue Next Year
  • BEAT N/A
  • LOAN N/A
  • P/E Ratio
  • BEAT N/A
  • LOAN $11.12
  • Revenue Growth
  • BEAT N/A
  • LOAN 9.69
  • 52 Week Low
  • BEAT $1.06
  • LOAN $4.27
  • 52 Week High
  • BEAT $3.39
  • LOAN $5.90
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 49.47
  • LOAN 53.78
  • Support Level
  • BEAT $2.06
  • LOAN $5.21
  • Resistance Level
  • BEAT $2.30
  • LOAN $5.71
  • Average True Range (ATR)
  • BEAT 0.13
  • LOAN 0.18
  • MACD
  • BEAT 0.01
  • LOAN -0.00
  • Stochastic Oscillator
  • BEAT 47.76
  • LOAN 44.93

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: